Cargando…
What is new about ovarian malignancies?
Ovarian cancer is one of the most prevalent pathologies in gynaecology. This malignancy can be divided into 2 large groups: epithelial and non-epithelial. Because epithelial ovarian cancers (EOC) are the most commonly diagnosed, this paper focuses on the latest therapies associated with this disease...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768052/ https://www.ncbi.nlm.nih.gov/pubmed/35079229 http://dx.doi.org/10.5114/wo.2021.112037 |
_version_ | 1784634836255768576 |
---|---|
author | Grabska, Kinga Pilarska, Izabela Fudalej, Marta Magdalena Deptała, Andrzej Badowska-Kozakiewicz, Anna |
author_facet | Grabska, Kinga Pilarska, Izabela Fudalej, Marta Magdalena Deptała, Andrzej Badowska-Kozakiewicz, Anna |
author_sort | Grabska, Kinga |
collection | PubMed |
description | Ovarian cancer is one of the most prevalent pathologies in gynaecology. This malignancy can be divided into 2 large groups: epithelial and non-epithelial. Because epithelial ovarian cancers (EOC) are the most commonly diagnosed, this paper focuses on the latest therapies associated with this disease. Due to the difficult diagnosis, EOC is frequently detected in the advanced stage. The treatment is usually complex and requires specialist knowledge. Advances and new ideas, such as identification of various genes and molecules that can serve as prognostic factors, might increase patients’ chances of survival; they may contribute to optimization of patients’ treatment, deciding whether to use aggressive treatment strategies, and predicting chemoresistance. Moreover, new strategies might also improve the quality of life of patients. The study aimed to analyse and discuss the latest reports on new methods of managing EOC. |
format | Online Article Text |
id | pubmed-8768052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-87680522022-01-24 What is new about ovarian malignancies? Grabska, Kinga Pilarska, Izabela Fudalej, Marta Magdalena Deptała, Andrzej Badowska-Kozakiewicz, Anna Contemp Oncol (Pozn) Review Paper Ovarian cancer is one of the most prevalent pathologies in gynaecology. This malignancy can be divided into 2 large groups: epithelial and non-epithelial. Because epithelial ovarian cancers (EOC) are the most commonly diagnosed, this paper focuses on the latest therapies associated with this disease. Due to the difficult diagnosis, EOC is frequently detected in the advanced stage. The treatment is usually complex and requires specialist knowledge. Advances and new ideas, such as identification of various genes and molecules that can serve as prognostic factors, might increase patients’ chances of survival; they may contribute to optimization of patients’ treatment, deciding whether to use aggressive treatment strategies, and predicting chemoresistance. Moreover, new strategies might also improve the quality of life of patients. The study aimed to analyse and discuss the latest reports on new methods of managing EOC. Termedia Publishing House 2021-12-29 2021 /pmc/articles/PMC8768052/ /pubmed/35079229 http://dx.doi.org/10.5114/wo.2021.112037 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Review Paper Grabska, Kinga Pilarska, Izabela Fudalej, Marta Magdalena Deptała, Andrzej Badowska-Kozakiewicz, Anna What is new about ovarian malignancies? |
title | What is new about ovarian malignancies? |
title_full | What is new about ovarian malignancies? |
title_fullStr | What is new about ovarian malignancies? |
title_full_unstemmed | What is new about ovarian malignancies? |
title_short | What is new about ovarian malignancies? |
title_sort | what is new about ovarian malignancies? |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768052/ https://www.ncbi.nlm.nih.gov/pubmed/35079229 http://dx.doi.org/10.5114/wo.2021.112037 |
work_keys_str_mv | AT grabskakinga whatisnewaboutovarianmalignancies AT pilarskaizabela whatisnewaboutovarianmalignancies AT fudalejmartamagdalena whatisnewaboutovarianmalignancies AT deptałaandrzej whatisnewaboutovarianmalignancies AT badowskakozakiewiczanna whatisnewaboutovarianmalignancies |